OPS
KPTI icon

Orion Portfolio Solutions’s Karyopharm Therapeutics KPTI Stock Holding History

Orion Portfolio Solutions’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-731
Closed -$10.1K – 1716
2023
Q4 		$10.1K Sell
731
-138
-16% -$1.86K ﹤0.01% 1647
2023
Q3 		$17.5K Buy
+869
New +$19.5K ﹤0.01% 1605
2020
Q1 		– Sell
-3
Closed -$1K – 2104
2019
Q4 		$1K Buy
+3
New +$651 ﹤0.01% 1680

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orion Portfolio Solutions's KPTI Position: Q1 2024 in Review

Orion Portfolio Solutions sold out of Karyopharm Therapeutics (KPTI) in Q1 2024, closing a stake of 731 shares — an estimated $10.1K sold.

Orion Portfolio Solutions first reported a position in KPTI in Q4 2019 and held it in 3 quarters. The position peaked at $17.5K in Q3 2023. 113 funds tracked by Wall St. Rank hold KPTI as of Q1 2024.

  • Orion Portfolio Solutions reported no remaining Karyopharm Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Orion Portfolio Solutions sold 731 Karyopharm Therapeutics shares in Q1 2024, an estimated $10.1K.
  • Orion Portfolio Solutions first reported a position in Karyopharm Therapeutics in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's Karyopharm Therapeutics position peaked at $17.5K in Q3 2023.
  • 113 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2024.

Based on Orion Portfolio Solutions's 13F filing for Q1 2024, filed 9 May 2024.